Mega Lifesciences Public Company Limited (MEGA-R) — Cash Flow Quality Index
Mega Lifesciences Public Company Limited (MEGA-R) has a Cash Flow Quality Index of 1.18x as of June 2025. Operating cash flow of ฿461.26 Million exceeds net income of ฿390.92 Million, indicating high earnings quality where cash backs reported profits. Explore Mega Lifesciences Public Company Limited debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Mega Lifesciences Public Company Limited Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Mega Lifesciences Public Company Limited across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Mega Lifesciences Public Company Limited.
Annual Cash Flow Quality Index for Mega Lifesciences Public Company Limited (2011–2024)
Year-by-year earnings quality comparison for Mega Lifesciences Public Company Limited.
| Year | Quality Index | Operating CF (THB) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.19x | ฿2.40 Billion | ฿2.01 Billion | ▲ +23.4% |
| 2023 | 0.97x | ฿1.93 Billion | ฿1.99 Billion | ▲ +8.5% |
| 2022 | 0.89x | ฿2.00 Billion | ฿2.24 Billion | ▼ -36.6% |
| 2021 | 1.40x | ฿2.73 Billion | ฿1.94 Billion | ▲ +19.7% |
| 2020 | 1.17x | ฿1.63 Billion | ฿1.39 Billion | ▼ -10.6% |
| 2019 | 1.31x | ฿1.50 Billion | ฿1.14 Billion | ▲ +72.3% |
| 2018 | 0.76x | ฿919.36 Million | ฿1.21 Billion | ▼ -8.5% |
| 2017 | 0.83x | ฿927.00 Million | ฿1.11 Billion | ▼ -47.5% |
| 2016 | 1.59x | ฿1.26 Billion | ฿794.94 Million | ▲ +81.1% |
| 2015 | 0.88x | ฿609.12 Million | ฿695.74 Million | ▼ -21.9% |
| 2014 | 1.12x | ฿614.22 Million | ฿547.85 Million | ▲ +50.2% |
| 2013 | 0.75x | ฿465.77 Million | ฿624.03 Million | ▲ +21.6% |
| 2012 | 0.61x | ฿342.02 Million | ฿557.11 Million | ▲ +5.5% |
| 2011 | 0.58x | ฿266.67 Million | ฿458.28 Million | — |